Filing Details

Accession Number:
0001179110-15-007534
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-11 17:04:04
Reporting Period:
2015-05-07
Filing Date:
2015-05-11
Accepted Time:
2015-05-11 17:04:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
815094 Abiomed Inc ABMD Surgical & Medical Instruments & Apparatus (3841) 042743260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1286370 R Michael Minogue C/O Abiomed, Inc.,
22 Cherry Hill Drive
Danvers MA 01923
President, Ceo, Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock $.01 Par Value Acquisiton 2015-05-07 42,798 $11.27 375,270 No 4 M Direct
Common Stock $.01 Par Value Disposition 2015-05-07 32,641 $70.00 342,629 No 4 S Direct
Common Stock $.01 Par Value Disposition 2015-05-07 5,036 $70.81 337,593 No 4 S Direct
Common Stock $.01 Par Value Disposition 2015-05-07 3,215 $71.85 334,378 No 4 S Direct
Common Stock $.01 Par Value Disposition 2015-05-07 1,596 $72.98 332,782 No 4 S Direct
Common Stock $.01 Par Value Disposition 2015-05-07 310 $73.74 332,472 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-05-07 42,798 $0.00 42,798 $11.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
42,202 2008-05-30 2017-05-30 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $13.57 2007-06-01 2016-06-01 0 82,000 Direct
Common Stock Stock Option (right to buy) $13.80 2009-05-23 2018-05-23 0 43,333 Direct
Common Stock Stock Option (right to buy) $18.63 2009-06-15 2018-08-13 0 76,875 Direct
Common Stock Stock Option (right to buy) $5.86 2010-05-28 2019-05-28 0 146,800 Direct
Common Stock Stock Option (right to buy) $5.86 2010-05-28 2019-05-28 0 56,700 Direct
Common Stock Stock Option (right to buy) $10.03 2011-06-03 2020-06-03 0 105,000 Direct
Common Stock Stock Option (Right to Buy) $22.44 2013-05-22 2022-05-22 0 50,000 Direct
Common Stock Stock Option (Right to Buy) $23.15 2014-05-14 2024-05-14 0 21,250 Direct
Common Stock Stock Option (right to buy) $21.55 2015-05-14 2024-05-14 0 85,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-06-01 0 82,000 Direct
2018-05-23 0 43,333 Direct
2018-08-13 0 76,875 Direct
2019-05-28 0 146,800 Direct
2019-05-28 0 56,700 Direct
2020-06-03 0 105,000 Direct
2022-05-22 0 50,000 Direct
2024-05-14 0 21,250 Direct
2024-05-14 0 85,000 Direct
Footnotes
  1. Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
  2. These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
  3. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
  4. These options become exercisable based on the achievement of certain performance milestones.
  5. Sale of common stock pursuant to reporting owner's 10b5-1 plan.
  6. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.5000 and $70.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  7. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $70.5000 and $71.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  8. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $71.5200 and $72.3400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  9. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $72.3900 and $73.3400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  10. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $73.4100 and $73.9000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.